s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
8-K
Financial results
Filed
Tuesday, May 7, 2024
Period
May 7, 2024
Accession number
0000950170-24-053933
Documents
Current report filing
8-K
99.1
Press release or other material
EX-99.1
Data files
1
Financial data and other files for software
101.SCH
XBRL Taxonomy Extension Schema with Embedded Linkbases Document
EX-101.SCH
On sec.gov
Filing index
All files
Complete submission text
SGML header